Publication:
Deprescribing to increase people health or when deprescribing could be the best pill

dc.contributor.authorEsteban Jimenez, Oscar
dc.contributor.authorArroyo Anies, Maria Pilar
dc.contributor.authorVicens-Caldentey, Caterina
dc.contributor.authorGonzalez Rubio, Francisca
dc.contributor.authorHernandez Rodriguez, Miguel Angel
dc.contributor.authorSempere Manuel, Mara
dc.date.accessioned2024-09-06T09:53:36Z
dc.date.available2024-09-06T09:53:36Z
dc.date.issued2018-11
dc.description.abstractThe increasing longevity of the population, the increase in morbidity and the consumption of medications have caused that polypharmacy is a priority health problem due to its consequences: increase of adverse effects, pharmacological interactions and favor the functional deterioration of the patient. The clinical situation of the patients changes over time and it is necessary to adjust the medication in each stage, assessing the fragility, the level of dependence and the functional deterioration. Deprescription is complex and requires an adequate clinical and pharmacological formation. In Primary Care lies the greater knowledge of the patient and their environment, and in a shared way with the patient and caregivers, it is necessary to assess which drugs to maintain and which ones to withdraw from a clinical, ethical and social perspective. There are tools to help deprescription that can be useful for Primary Care to facilitate this process and that are detailed in this article.en
dc.format.numbers2es_ES
dc.format.page70-79es_ES
dc.format.volume50es_ES
dc.identifier.citationEsteban Jimenez O, Arroyo Anies MP, Vicens Caldentey C, Gonzalez Rubio F, Hernandez Rodriguez MA, Sempere M Mara. Deprescribing to increase people health or when deprescribing could be the best pill. Aten Prim. 2018 Nov;50(Suppl 2):70-9. Epub 2018 Sep 29.en
dc.identifier.doi10.1016/j.aprim.2018.09.001
dc.identifier.e-issn1578-1275es_ES
dc.identifier.issn0212-6567
dc.identifier.journalAtencion Primariaes_ES
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/17276
dc.identifier.pubmedID30279013es_ES
dc.identifier.puiL2001145292
dc.identifier.scopus2-s2.0-85054064764
dc.identifier.urihttps://hdl.handle.net/20.500.12105/22508
dc.identifier.wos455490200010
dc.language.isospaen
dc.publisherElsevier
dc.relation.publisherversionhttps://dx.doi.org/10.1016/j.aprim.2018.09.001en
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPolypharmacy
dc.subjectInappropriate prescribing
dc.subjectFrail elderly
dc.subjectDeprescription
dc.subjectDrug therapy
dc.subject.decsPolifarmacia*
dc.subject.decsHumanos*
dc.subject.decsEnfermedades Neurodegenerativas*
dc.subject.decsAnciano*
dc.subject.decsMedicina Familiar y Comunitaria*
dc.subject.decsAtención Primaria de Salud*
dc.subject.decsDeprescripciones*
dc.subject.decsCuidado Terminal*
dc.subject.decsAnciano Frágil*
dc.subject.meshAged*
dc.subject.meshFrail Elderly*
dc.subject.meshTerminal Care*
dc.subject.meshFamily Practice*
dc.subject.meshNeurodegenerative Diseases*
dc.subject.meshHumans*
dc.subject.meshPolypharmacy*
dc.subject.meshPrimary Health Care*
dc.subject.meshDeprescriptions*
dc.titleDeprescribing to increase people health or when deprescribing could be the best pillen
dc.typeresearch articleen
dspace.entity.typePublication
relation.isPublisherOfPublication7d471502-7bd5-4f7a-90a4-8274382509ef
relation.isPublisherOfPublication.latestForDiscovery7d471502-7bd5-4f7a-90a4-8274382509ef

Files